Xvivo Perfusion
392 SEK -1,01%1 investor følger denne virksomhed
Xvivo Perfusion is a medical technology company. The company provides solutions for lung transplantation. Examples of products that the company delivers include needles, organ storage, and cooling solutions. The products are resold to clinics and research institutes around the global market, with the largest business presence in the Nordics and Europe. The company was established via a spin-off from Vitrolife in 2012 and is headquartered in Gothenburg.
Omsætning
597,54 mio.
EBIT %
0,7 %
P/E
127,69
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
XVIVO
Daglig lav / høj pris
390 / 399
SEK
Markedsværdi
12,35 mia. SEK
Aktieomsætning
8,02 mio. SEK
Volumen
20 t
Seneste videoer
Finanskalender
Delårsrapport
12.07.2024
Delårsrapport
24.10.2024
Årsrapport
28.01.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Bure Equity | 14,3 % | 14,3 % |
Fjärde AP-fonden | 9,0 % | 9,0 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Redeye: XVIVO Q1 - Back on track
XVIVO, Audiocast with teleconference, Q1, 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools